Alector
The Scientist role involves designing and executing in vitro studies and analytical assays to evaluate potential therapeutics for neurodegenerative diseases. The position requires working with advanced cellular models and generating high-quality data to inform pharmacokinetics, efficacy, and safety studies. Collaboration with cross-functional teams is essential to advance therapeutic programs and integrate innovative technologies.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2013
Alector is a biopharmaceutical company focused on discovering and developing therapies for neurodegenerative diseases. The company applies neuroimmunology — harnessing the immune system and genetic insights — to target the underlying biology driving brain disorders. Alector advances programs from discovery into clinical development with the goal of slowing or stopping neurodegeneration and improving patient outcomes.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alector.